 |
[Alpha Biz=(Chicago) Reporter Kim Jisun] Lee Woo-hyun, chairman of OCI Holdings, became the sole CEO of Bukwang Pharmaceutical (003000). OCI Holdings (010060) took over Bukwang Pharmaceutical last year.
Bukwang Pharmaceutical announced on the 17th that it will change its representative system from Lee Woo-hyun and Yoo Hee-won to Lee Woo-hyun's sole representative system. Bukwang Pharmaceutical explained, "It is a change following the resignation of Yoo Hee-won, each CEO."
OCI, an energy and chemical company, became the largest shareholder in February last year by acquiring a 10.9% stake in Bukwang Pharmaceutical. OCI Holdings is also actively investing in bio companies such as SN Bioscience and Panoros Bioscience through Synergy Healthcare Fund.
AlphaBIZ 김지선(stockmk2020@alphabiz.co.kr)
